Management of Post-Traumatic Stress Disorder (PTSD)

Introduction to PTSD Management

The American College of Physicians and the American Academy of Sleep Medicine recommend trauma-focused psychotherapy as the first attempt for PTSD treatment, with the strongest evidence 1, 2
Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) are recommended as first-line pharmacological treatments for PTSD due to their FDA approval and strong evidence supporting their efficacy, according to the American College of Physicians and the American Academy of Sleep Medicine 2, 3, 4

The American Academy of Sleep Medicine suggests that Lamotrigine has shown efficacy in a small controlled study for managing flashbacks associated with impulsivity and anger 5
Cyproheptadine may worsen flashbacks in some patients, despite being used for nightmares, as noted by the American Academy of Sleep Medicine 5
Clonidine is not recommended as a first-line treatment for general anxiety, but has a Level C recommendation for PTSD-associated nightmares, according to the American Academy of Sleep Medicine, with doses of 0.1-0.6 mg daily showing benefit in small studies 6, 5
Prazosin may be specifically used to target PTSD-related nightmares, with a starting dose of 1 mg at bedtime and an average effective dose of 3 mg, as recommended by the American Academy of Sleep Medicine and the International Society for Traumatic Stress Studies 5, 6
Trazodone can be considered if sleep disturbance is prominent, but be aware of potential side effects, according to the American Academy of Sleep Medicine 6
Atypical antipsychotics may be considered for PTSD with prominent paranoia or flashbacks, and can be used as augmentation to SSRIs in refractory cases, as recommended by the American Academy of Sleep Medicine 5, 6
Benzodiazepines should be avoided in PTSD as they may worsen outcomes, according to the American College of Physicians and the American Academy of Sleep Medicine, with moderate-certainty evidence supporting their ineffectiveness in controlled studies 2, 3

Trauma-focused psychotherapies, including prolonged exposure therapy, cognitive processing therapy, and eye movement desensitization and reprocessing (EMDR), are strongly recommended for PTSD treatment, as they have been shown to be effective in reducing symptoms, according to the American College of Physicians and the American Academy of Sleep Medicine 2, 6, 7
Image rehearsal therapy is recommended for PTSD-associated nightmares, as it has been shown to be effective in reducing nightmare frequency and severity, according to the American Academy of Sleep Medicine 5
A phase-based approach, with stabilization before trauma processing, is recommended for complex PTSD, as it can help reduce symptoms and improve treatment outcomes, according to the American College of Physicians 7
Secure video teleconferencing is recommended for delivering psychotherapy when in-person options are unavailable, as it can provide equal or better treatment outcomes compared to in-person therapy, according to the American College of Physicians 2

The American College of Physicians recommends that patients with PTSD receive treatment for at least 12-24 months after achieving remission to prevent relapse, as this can help reduce the risk of recurrence 2
The American Psychiatric Association and the American College of Neuropsychopharmacology suggest continuing medication for at least 12-24 months after achieving remission to prevent relapse, with relapse rates significantly lower when medication is maintained (5-16% vs. 26-52% when discontinued) 3, 5
Patients should be monitored closely during initial weeks for worsening symptoms, suicidal ideation, and side effects, particularly when using atypical antipsychotics, according to the American Academy of Sleep Medicine 5, 6

Comorbidities such as depression, anxiety, and substance use disorders should be addressed in PTSD treatment, according to the American College of Physicians 1
Close monitoring is necessary during initial weeks for worsening symptoms, suicidal ideation, and side effects, according to the American College of Physicians 1
Premature discontinuation of treatment, inadequate dosing, overlooking nightmares, ignoring comorbidities, and benzodiazepine use are common pitfalls that can worsen PTSD outcomes, and regular monitoring for side effects, suicidal ideation, and treatment response is essential for optimal management, according to the American Academy of Sleep Medicine 6